Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Toledo › NPI 1407854771
Physician

The Toledo Hospital

The Toledo Hospital was paid $151.22M by Medicaid between Jan 2018 and Dec 2024, across 777 billing codes. Its largest line is 99283, emergency room visit (moderate) — 9.9% of everything it billed.

33Billing provider infoTHE TOLEDO HOSPITAL
TOLEDO, OH 43606
33aNPI1407854771assigned 07/12/2005
33bProvider typePediatrics Physician
28Total paid$151.22M
24GClaims3,399,237
24DCodes billed777
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pediatrics Physician providers in Ohio

Rank by total paid#1 of 401
Median peer was paid$30K
This provider vs. median5,123×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$2.0M$4.0M$6.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018250,814$10.02M
2019284,831$11.44M
2020252,192$13.25M
2021336,623$17.63M
2022358,030$17.45M
20231,034,643$47.00M
2024incomplete882,104$34.43M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 9.9% 133,430 123,531 $14.97M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 8.3% 93,782 83,215 $12.62M
96361 Intravenous infusion, hydration; each additional hour 6.0% 33,720 23,780 $9.04M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 5.7% 119,565 76,579 $8.55M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3.4% 30,897 29,139 $5.12M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.2% 29,128 25,131 $4.83M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 2.4% 46,587 31,556 $3.60M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 1.9% 42,368 26,516 $2.95M
81514 1.8% 17,802 15,165 $2.70M
70450 Computed tomography, head or brain; without contrast material 1.7% 10,628 9,126 $2.52M
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 1.6% 36,942 22,595 $2.49M
G0378 Hospital observation service, per hour 1.6% 20,915 8,955 $2.46M
765 more codes
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.5% 23,945 $2.29M
74177 Computed tomography, abdomen and pelvis; with contrast material 1.4% 9,584 $2.13M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.4% 30,142 $2.13M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.3% 13,761 $1.94M
96127 1.3% 27,000 $1.92M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 1.3% 27,447 $1.90M
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1.2% 25,625 $1.84M
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 1.2% 29,371 $1.77M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.1% 6,383 $1.66M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.1% 19,464 $1.62M
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 8,730 $1.49M
59025 Fetal non-stress test <1% 16,898 $1.48M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 43,881 $1.33M
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 16,157 $1.15M
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 7,224 $1.15M
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study <1% 3,861 $1.14M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 9,777 $1.11M
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 15,898 $1.10M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 5,674 $1.07M
80053 Comprehensive metabolic panel <1% 102,983 $1.06M
92551 <1% 24,259 $1.02M
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 14,407 $998K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 640 $872K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 6,183 $858K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 2,233 $848K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 9,997 $838K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 43,885 $794K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 1,851 $753K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 1,094 $745K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,982 $721K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 2,586 $690K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 8,495 $682K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 25,168 $644K
92552 <1% 11,287 $628K
84443 Thyroid stimulating hormone (TSH) <1% 40,270 $627K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 14,805 $609K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 1,258 $604K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 17,049 $590K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 1,231 $568K
47562 <1% 250 $568K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 177,156 $565K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 22,376 $552K
71275 Computed tomographic angiography, chest, with contrast material <1% 2,172 $531K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 13,647 $497K
90837 Psychotherapy session, about an hour <1% 6,410 $496K
99215 Doctor's office visit, returning patient (complex) <1% 4,436 $457K
80048 Basic metabolic panel (calcium, ionized) <1% 59,107 $454K
58661 <1% 224 $444K
80061 Lipid panel <1% 29,340 $436K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 413 $418K
93325 <1% 4,539 $400K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 63,301 $400K
36415 Collection of venous blood by venipuncture <1% 159,773 $399K
94010 <1% 2,772 $386K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 46,069 $370K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 6,278 $369K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 4,078 $356K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 589 $352K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 745 $352K
93458 <1% 266 $347K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,239 $347K
71046 Radiologic examination, chest; 2 views <1% 17,258 $346K
97803 <1% 4,411 $344K
84439 <1% 24,656 $335K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 546 $332K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 18,110 $328K
82607 <1% 14,830 $325K
87086 Culture, bacterial; quantitative colony count, urine <1% 31,545 $323K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 547 $315K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 7,875 $313K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 3,534 $300K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 5,980 $298K
96415 <1% 1,251 $288K
78815 Positron emission tomography (PET) for limited area imaging <1% 501 $287K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 3,641 $273K
76770 <1% 1,720 $266K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 6,863 $264K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 3,130 $260K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 12,130 $251K
86780 <1% 13,124 $243K
83036 Hemoglobin; glycosylated (A1C) <1% 20,594 $235K
86850 <1% 10,790 $227K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,768 $225K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 15,310 $216K
70491 <1% 769 $207K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 5,621 $201K
82728 <1% 13,151 $201K
85027 <1% 28,591 $193K
70551 Magnetic resonance imaging, brain; without contrast material <1% 1,067 $190K
70496 <1% 869 $190K
87480 <1% 10,159 $182K
76820 <1% 6,546 $178K
52000 <1% 299 $173K
95816 <1% 1,096 $173K
A0425 Ground mileage, per statute mile <1% 3,048 $170K
93975 <1% 1,468 $169K
99232 Hospital visit by a doctor, follow-up day <1% 6,192 $164K
96367 <1% 3,088 $161K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 1,133 $161K
87510 <1% 10,147 $154K
93970 <1% 1,177 $153K
86900 <1% 10,511 $150K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,463 $149K
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) <1% 677 $149K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 729 $146K
76642 <1% 1,412 $146K
74018 <1% 4,278 $142K
97802 <1% 1,741 $141K
97113 <1% 2,018 $141K
83540 <1% 15,879 $141K
A0428 Ambulance service, basic life support, non-emergency transport, (bls) <1% 1,471 $140K
43235 <1% 357 $140K
87660 <1% 10,951 $136K
87150 <1% 4,373 $135K
71045 Radiologic examination, chest; single view <1% 24,381 $132K
83970 <1% 4,617 $132K
93017 <1% 1,631 $129K
64615 <1% 563 $128K
97162 <1% 3,031 $126K
97010 <1% 3,401 $125K
83655 <1% 7,093 $124K
J9271 Injection, pembrolizumab, 1 mg <1% 22 $124K
77063 Screening digital breast tomosynthesis, bilateral <1% 2,971 $124K
76801 <1% 3,645 $123K
97161 <1% 2,381 $120K
72141 <1% 777 $118K
64483 <1% 256 $118K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 42,368 $116K
J1756 Injection, iron sucrose, 1 mg <1% 3,707 $115K
12001 <1% 742 $114K
94060 <1% 1,025 $112K
75574 <1% 474 $110K
A0426 Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) <1% 1,087 $108K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 505 $108K
76536 <1% 1,030 $105K
80076 <1% 9,400 $104K
84484 <1% 34,640 $102K
83550 <1% 13,119 $102K
99381 <1% 2,680 $101K
58571 <1% 32 $97K
J7307 Etonogestrel (contraceptive) implant system, including implant and supplies <1% 81 $94K
41899 Unlisted procedure, dentoalveolar structures <1% 105 $93K
74183 <1% 491 $93K
84702 <1% 6,068 $92K
76830 Ultrasound, transvaginal <1% 2,511 $91K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 956 $91K
P9016 Red blood cells, leukocytes reduced, each unit <1% 432 $90K
87507 <1% 951 $90K
96375 Therapeutic injection; each additional sequential IV push <1% 31,824 $89K
12011 <1% 584 $88K
99177 <1% 10,409 $87K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 17,641 $87K
92567 <1% 2,809 $85K
86140 <1% 9,472 $85K
90686 <1% 12,668 $84K
76819 Fetal biophysical profile; without non-stress testing <1% 1,338 $83K
73562 <1% 4,250 $83K
71250 <1% 987 $83K
82570 <1% 10,052 $82K
97166 <1% 1,476 $80K
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 5,022 $80K
86803 <1% 5,883 $79K
86762 <1% 4,999 $77K
76825 <1% 1,121 $77K
83735 <1% 26,261 $77K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 6,877 $76K
74240 <1% 521 $75K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 2,947 $75K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 28,044 $73K
87340 <1% 6,066 $72K
10060 <1% 465 $72K
72100 <1% 2,621 $72K
82746 <1% 6,906 $69K
36430 <1% 609 $69K
74174 <1% 598 $67K
80074 <1% 3,329 $67K
93971 <1% 812 $66K
97535 Self-care/home management training, each 15 minutes <1% 2,500 $66K
70486 <1% 1,218 $65K
94726 <1% 1,470 $64K
71271 <1% 466 $64K
77336 <1% 600 $63K
95819 <1% 358 $62K
77300 <1% 124 $62K
73610 <1% 3,086 $60K
59430 <1% 586 $60K
92588 <1% 531 $60K
94619 <1% 510 $60K
72110 <1% 1,046 $59K
92557 <1% 781 $59K
87077 <1% 8,617 $58K
77334 <1% 230 $58K
86787 <1% 3,536 $58K
90670 <1% 9,416 $58K
73030 <1% 2,881 $58K
73221 <1% 310 $57K
87081 <1% 4,313 $56K
72040 <1% 1,417 $56K
86901 <1% 10,458 $56K
81001 <1% 14,354 $55K
84481 <1% 3,863 $54K
D7140 Extraction, erupted tooth or exposed root <1% 88 $54K
77290 <1% 94 $53K
99188 <1% 2,719 $52K
95811 <1% 105 $51K
72125 Computed tomography, cervical spine; without contrast material <1% 3,403 $50K
70498 <1% 975 $50K
73630 <1% 3,228 $49K
88307 <1% 650 $49K
93225 <1% 551 $49K
93880 <1% 652 $49K
J1745 Injection, infliximab, excludes biosimilar, 10 mg <1% 14 $48K
86038 <1% 2,447 $48K
72197 <1% 199 $48K
90710 <1% 7,750 $47K
76818 <1% 701 $47K
94762 <1% 834 $46K
90651 <1% 6,182 $46K
77067 Screening mammography, bilateral, including computer-aided detection <1% 3,082 $46K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 317 $46K
73502 <1% 1,884 $45K
86003 <1% 1,722 $45K
92523 <1% 788 $45K
87186 <1% 6,352 $44K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 4,953 $44K
99238 Hospital discharge day management, 30 minutes or less <1% 1,468 $44K
93923 <1% 627 $44K
99460 <1% 585 $43K
93308 <1% 167 $43K
83525 <1% 2,000 $42K
88348 <1% 419 $42K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 2,207 $41K
73700 <1% 385 $40K
82950 <1% 4,191 $40K
90715 <1% 4,319 $39K
92526 <1% 654 $39K
86480 <1% 991 $39K
78800 <1% 51 $39K
12002 <1% 277 $39K
76813 <1% 833 $39K
95700 <1% 306 $38K
74230 <1% 373 $38K
86592 <1% 1,069 $38K
97116 <1% 1,748 $38K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 193 $38K
81003 <1% 63,635 $37K
86800 <1% 1,382 $37K
82670 <1% 1,539 $36K
36591 <1% 3,411 $36K
94772 <1% 246 $36K
85610 <1% 21,839 $36K
D2930 Prefabricated stainless steel crown - primary tooth <1% 50 $35K
82043 <1% 5,385 $35K
73130 <1% 2,701 $35K
90999 Dialysis (unlisted procedure) <1% 197 $35K
72050 <1% 594 $34K
84403 <1% 2,101 $34K
52356 <1% 19 $33K
73564 <1% 692 $32K
85652 <1% 7,719 $32K
72120 <1% 556 $32K
73110 <1% 1,773 $32K
84153 <1% 2,180 $32K
82784 <1% 2,516 $32K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 345 $31K
76886 <1% 292 $31K
87529 <1% 889 $31K
86696 <1% 1,044 $30K
77062 <1% 826 $30K
87070 <1% 3,773 $30K
94729 <1% 476 $29K
95806 <1% 72 $29K
86364 <1% 1,304 $28K
77080 <1% 524 $28K
99078 <1% 1,007 $28K
95885 <1% 106 $27K
87522 Neg quan hep c or qual rna <1% 775 $27K
84146 <1% 1,839 $26K
72158 <1% 170 $26K
72072 <1% 943 $25K
72131 <1% 615 $25K
86706 <1% 1,505 $25K
88184 <1% 395 $25K
82565 <1% 5,026 $25K
83001 <1% 1,523 $25K
77049 <1% 66 $25K
82785 <1% 1,622 $24K
20680 <1% 22 $24K
82105 <1% 1,575 $24K
92652 <1% 566 $24K
86235 <1% 1,536 $24K
19083 <1% 28 $24K
82248 <1% 2,520 $24K
97533 <1% 395 $23K
81025 <1% 43,337 $23K
86704 <1% 895 $23K
97163 <1% 455 $23K
0012A <1% 633 $22K
72156 <1% 177 $22K
86376 <1% 1,467 $22K
73590 <1% 1,423 $22K
97165 <1% 331 $22K
87493 <1% 805 $22K
93304 <1% 70 $21K
76870 <1% 517 $21K
J7298 Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg <1% 19 $21K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 209 $20K
76882 <1% 237 $20K
86431 <1% 1,474 $20K
86200 <1% 731 $19K
78264 <1% 92 $19K
87205 <1% 3,291 $19K
58558 <1% 17 $19K
96376 <1% 11,576 $19K
77065 Tomosynthesis, mammo <1% 821 $19K
96368 <1% 1,220 $18K
82533 <1% 939 $18K
84425 <1% 1,665 $18K
83020 <1% 1,538 $18K
88341 <1% 355 $18K
84100 <1% 5,845 $18K
99222 Initial hospital care, per day, moderate complexity <1% 342 $18K
95714 <1% 33 $17K
J3490 Unclassified drugs <1% 1,919 $17K
82310 <1% 1,622 $17K
92579 <1% 313 $17K
73560 <1% 573 $17K
82525 <1% 1,085 $17K
92611 <1% 365 $16K
99244 Office or other outpatient consultation, moderate to high complexity <1% 309 $16K
84590 <1% 835 $16K
95911 <1% 60 $16K
H1000 Prenatal care, at-risk assessment <1% 663 $16K
0011A <1% 741 $16K
86870 <1% 499 $15K
84156 <1% 4,468 $15K
83002 <1% 1,087 $15K
99243 <1% 515 $15K
77061 <1% 379 $15K
73552 <1% 800 $15K
83690 <1% 19,720 $15K
54150 <1% 291 $14K
83880 <1% 3,964 $14K
77072 <1% 197 $14K
86695 <1% 1,004 $14K
83021 <1% 1,041 $14K
90677 <1% 1,731 $14K
72081 <1% 245 $14K
87631 <1% 214 $14K
82951 <1% 681 $14K
64643 <1% 25 $14K
86147 <1% 435 $13K
84550 <1% 3,452 $13K
82627 <1% 512 $13K
85014 <1% 4,904 $13K
54161 <1% 25 $13K
88185 <1% 385 $13K
85246 <1% 645 $13K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 2,723 $13K
82550 <1% 2,377 $13K
73080 <1% 1,099 $13K
81596 <1% 120 $13K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 461 $13K
77066 Tomosynthesis, mammo <1% 965 $13K
70544 <1% 71 $12K
S9445 Patient education, not otherwise classified, non-physician provider, individual, per session <1% 419 $12K
99383 <1% 220 $12K
86225 <1% 451 $12K
0002A <1% 334 $12K
84402 <1% 768 $12K
80323 <1% 516 $12K
85730 <1% 7,472 $11K
83993 <1% 726 $11K
84630 <1% 1,023 $11K
83615 <1% 2,943 $11K
0001A <1% 370 $11K
97012 <1% 435 $11K
73090 <1% 954 $11K
43248 <1% 42 $11K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 739 $11K
59812 <1% 13 $11K
72146 <1% 133 $11K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 1,231 $10K
99152 <1% 858 $10K
86160 <1% 838 $10K
90620 <1% 1,566 $10K
85576 <1% 547 $10K
83013 <1% 204 $10K
82947 <1% 2,435 $10K
88342 <1% 988 $9K
84144 <1% 403 $9K
87102 <1% 851 $9K
73140 <1% 552 $9K
85379 <1% 6,496 $9K
77280 <1% 60 $9K
77301 <1% 13 $9K
11045 <1% 47 $9K
72128 <1% 273 $9K
85018 <1% 5,321 $9K
83520 <1% 403 $9K
86705 <1% 313 $9K
58300 <1% 103 $8K
85397 <1% 598 $8K
59514 <1% 12 $8K
86735 <1% 227 $8K
70360 <1% 264 $8K
95886 <1% 28 $7K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,294 $7K
82952 <1% 579 $7K
71101 <1% 577 $7K
0071A <1% 174 $7K
99204 Doctor's office visit, new patient (more involved) <1% 127 $7K
82024 <1% 277 $7K
96523 <1% 186 $7K
99462 <1% 202 $7K
99205 Prolong outpt/office vis <1% 97 $7K
82150 <1% 3,539 $6K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 7,654 $6K
84132 <1% 3,253 $6K
81229 <1% 26 $6K
92587 <1% 56 $6K
84270 <1% 477 $6K
84165 <1% 771 $6K
73000 <1% 166 $6K
88142 <1% 336 $6K
72170 <1% 975 $6K
82247 <1% 2,088 $6K
76857 <1% 68 $6K
84460 <1% 2,636 $6K
85045 <1% 2,490 $6K
99173 <1% 2,892 $6K
84681 <1% 393 $6K
86334 <1% 467 $6K
87206 <1% 844 $6K
82977 <1% 2,261 $6K
86304 <1% 362 $5K
84305 <1% 229 $5K
73521 <1% 96 $5K
84445 <1% 143 $5K
86146 <1% 373 $5K
90461 <1% 23,779 $5K
83521 <1% 459 $5K
25605 <1% 13 $5K
93312 <1% 30 $5K
84410 <1% 134 $5K
73060 <1% 465 $5K
94664 <1% 3,382 $5K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 283 $5K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 32 $5K
93320 <1% 3,892 $5K
80197 <1% 369 $5K
73523 <1% 115 $5K
86765 <1% 260 $5K
99153 Mod sedat endo service >5yrs <1% 642 $5K
74019 <1% 1,009 $4K
J2997 Injection, alteplase recombinant, 1 mg <1% 68 $4K
83605 <1% 6,260 $4K
87563 <1% 116 $4K
74420 <1% 37 $4K
92610 <1% 180 $4K
88112 <1% 520 $4K
82378 <1% 557 $4K
80051 <1% 1,893 $4K
84154 <1% 224 $4K
0072A <1% 106 $4K
88304 <1% 836 $4K
83721 <1% 331 $4K
80164 <1% 297 $4K
84703 <1% 824 $4K
86920 <1% 174 $4K
82040 <1% 2,107 $4K
85048 <1% 658 $4K
99239 Hospital discharge day management, more than 30 minutes <1% 68 $3K
84450 <1% 2,016 $3K
Q9957 Injection, perflutren lipid microspheres, per ml <1% 551 $3K
87040 <1% 2,432 $3K
83516 <1% 206 $3K
99203 Doctor's office visit, new patient (routine) <1% 109 $3K
77338 <1% 14 $3K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 333 $3K
82330 <1% 689 $3K
85049 <1% 1,380 $3K
78227 <1% 16 $3K
87210 <1% 1,423 $3K
0124A <1% 80 $3K
73100 <1% 145 $3K
86665 <1% 174 $3K
99221 <1% 82 $3K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 1,116 $3K
99384 <1% 44 $3K
81015 <1% 522 $3K
83498 <1% 160 $3K
74022 <1% 317 $3K
84145 <1% 1,363 $3K
85240 <1% 639 $3K
86036 <1% 211 $3K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 12 $3K
74178 <1% 15 $3K
99382 <1% 51 $3K
82077 <1% 3,525 $3K
99458 <1% 124 $3K
80354 <1% 313 $3K
80177 <1% 421 $3K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 61 $3K
J9045 Injection, carboplatin, 50 mg <1% 136 $2K
D2391 Resin-based composite - one surface, posterior, primary or permanent <1% 13 $2K
58100 <1% 12 $2K
84520 <1% 2,149 $2K
84134 <1% 217 $2K
76826 <1% 50 $2K
97750 <1% 61 $2K
82103 <1% 154 $2K
85613 <1% 317 $2K
97167 <1% 54 $2K
83921 <1% 231 $2K
86255 <1% 166 $2K
99242 <1% 124 $2K
C2629 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, laser <1% 413 $2K
82140 <1% 497 $2K
87641 <1% 100 $2K
95251 <1% 100 $2K
96417 <1% 825 $2K
A9270 Non-covered item or service <1% 1,032 $2K
86308 <1% 334 $2K
93702 <1% 12 $2K
29515 <1% 252 $2K
11043 <1% 28 $2K
80047 <1% 3,477 $2K
86039 <1% 201 $2K
J1453 Injection, fosaprepitant, 1 mg <1% 137 $2K
87486 <1% 209 $2K
86341 <1% 76 $2K
84207 <1% 168 $2K
86355 <1% 47 $2K
0154A <1% 41 $2K
89051 <1% 592 $2K
C1769 Guide wire <1% 2,834 $2K
86360 <1% 58 $2K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 16 $2K
99442 <1% 44 $1K
99464 <1% 24 $1K
64642 <1% 41 $1K
86923 <1% 79 $1K
97804 <1% 15 $1K
73070 <1% 83 $1K
80175 <1% 133 $1K
85384 <1% 1,061 $1K
98968 <1% 36 $1K
87581 <1% 209 $1K
82803 <1% 1,328 $1K
86317 <1% 108 $1K
87338 <1% 59 $1K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 14 $1K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 9,270 $1K
0064A <1% 31 $1K
85245 <1% 80 $1K
99385 <1% 27 $1K
99252 <1% 43 $1K
G0109 Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes <1% 27 $1K
86015 <1% 58 $1K
90656 <1% 112 $1K
86359 <1% 47 $1K
86357 <1% 47 $1K
99245 <1% 12 $1K
82010 <1% 994 $1K
99457 <1% 74 $1K
86880 <1% 53 $1K
0031A <1% 39 $1K
84432 <1% 58 $1K
J2704 Injection, propofol, 10 mg <1% 7,321 $1K
77002 <1% 16 $1K
29125 <1% 369 $1K
84075 <1% 1,739 $1K
97016 <1% 28 $970.13
95711 <1% 29 $943.15
76937 <1% 95 $931.64
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 19,977 $913.61
83874 <1% 612 $892.17
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 5,143 $858.83
C9290 Injection, bupivacaine liposome, 1 mg <1% 219 $849.60
87503 <1% 53 $825.16
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 62 $802.73
80143 <1% 915 $785.00
99386 <1% 13 $733.18
87116 <1% 137 $705.26
99454 <1% 37 $696.01
88360 <1% 13 $676.59
J1170 Injection, hydromorphone, up to 4 mg <1% 1,259 $621.22
0054A <1% 14 $608.29
86231 <1% 17 $527.51
J2785 Injection, regadenoson, 0.1 mg <1% 887 $526.90
J3475 Injection, magnesium sulfate, per 500 mg <1% 4,061 $509.58
J7050 Infusion, normal saline solution, 250 cc <1% 5,741 $504.97
81050 <1% 88 $474.29
72157 <1% 13 $461.50
J0736 Injection, clindamycin phosphate, 300 mg <1% 380 $452.81
81002 <1% 2,766 $451.10
86008 <1% 20 $444.17
86301 <1% 30 $427.02
86708 <1% 33 $418.48
82088 <1% 20 $411.18
87634 <1% 512 $361.24
83835 <1% 20 $360.95
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,081 $359.96
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 675 $354.22
G0008 Administration of influenza virus vaccine <1% 42 $353.65
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,580 $347.78
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 188 $329.93
82397 <1% 15 $322.51
82955 <1% 16 $318.63
96380 <1% 23 $315.82
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 670 $312.84
J1644 Injection, heparin sodium, per 1000 units <1% 1,481 $311.13
99251 <1% 14 $306.75
88300 <1% 474 $305.60
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 7,291 $303.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 689 $298.56
82164 <1% 26 $293.05
87106 <1% 12 $290.25
A4648 Tissue marker, implantable, any type, each <1% 317 $284.23
84478 <1% 53 $278.40
80179 <1% 822 $275.14
82542 <1% 30 $272.12
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 41 $267.86
87075 <1% 283 $258.35
A0130 Non-emergency transportation: wheelchair van <1% 15 $256.20
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 1,502 $255.90
J0780 Injection, prochlorperazine, up to 10 mg <1% 1,131 $252.84
J3010 Injection, fentanyl citrate, 0.1 mg <1% 7,824 $250.52
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 575 $250.36
80202 <1% 20 $224.43
51702 <1% 60 $218.65
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 1,385 $215.22
84244 <1% 17 $214.11
36416 <1% 464 $210.51
82653 <1% 13 $209.41
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 5,050 $208.17
84300 <1% 91 $205.59
82365 <1% 24 $202.67
83010 <1% 16 $202.09
51701 <1% 512 $200.19
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 1,567 $194.91
87140 <1% 19 $194.33
82272 <1% 60 $192.27
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 7,028 $189.38
96411 <1% 31 $188.25
82274 <1% 16 $178.06
84155 <1% 1,558 $171.99
85670 <1% 184 $167.94
80178 <1% 17 $167.22
87110 <1% 19 $156.69
80183 <1% 12 $151.71
84446 <1% 13 $143.03
86645 <1% 12 $140.59
73660 <1% 25 $132.39
J0360 Injection, hydralazine hcl, up to 20 mg <1% 384 $131.63
86381 <1% 14 $126.24
J0690 Injection, cefazolin sodium, 500 mg <1% 2,491 $125.89
82390 <1% 12 $107.61
85520 <1% 58 $102.67
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,790 $93.27
29105 <1% 15 $93.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 59 $90.56
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 2,878 $80.07
J3480 Injection, potassium chloride, per 2 meq <1% 1,380 $77.29
J2060 Injection, lorazepam, 2 mg <1% 549 $63.08
92227 <1% 15 $61.22
94760 <1% 1,828 $59.98
J1940 Injection, furosemide, up to 20 mg <1% 328 $58.70
J7999 Compounded drug, not otherwise classified <1% 1,177 $58.05
J3370 Injection, vancomycin hcl, 500 mg <1% 733 $57.19
69210 <1% 44 $52.95
82945 <1% 14 $49.37
S0209 Wheelchair van, mileage, per mile <1% 15 $43.41
J1580 Injection, garamycin, gentamicin, up to 80 mg <1% 258 $42.21
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,202 $39.44
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 282 $37.78
J2469 Injection, palonosetron hcl, 25 mcg <1% 272 $35.29
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 768 $34.79
J1171 Injection, hydromorphone, 0.1 mg <1% 316 $34.20
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 178 $33.58
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 15 $31.68
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 90 $31.24
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 252 $30.86
J2471 Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg <1% 117 $28.82
83930 <1% 14 $25.86
J1836 Injection, metronidazole, 10 mg <1% 447 $24.94
88302 <1% 256 $22.65
J1650 Injection, enoxaparin sodium, 10 mg <1% 19 $21.76
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 954 $20.82
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg <1% 116 $20.75
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg <1% 30 $19.00
85347 <1% 47 $15.98
91301 <1% 1,392 $11.89
J1805 Injection, esmolol hydrochloride, 10 mg <1% 22 $11.80
J1953 Injection, levetiracetam, 10 mg <1% 38 $10.82
88720 <1% 15 $10.75
88173 <1% 18 $9.92
J1596 Injection, glycopyrrolate, 0.1 mg <1% 521 $9.33
99441 <1% 13 $9.29
J1920 Injection, labetalol hydrochloride, 5 mg <1% 528 $9.08
73600 <1% 13 $8.45
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,969 $8.03
91300 <1% 888 $7.36
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 388 $7.10
J1630 Injection, haloperidol, up to 5 mg <1% 226 $6.98
C1729 Catheter, drainage <1% 677 $5.94
91307 <1% 583 $5.63
J3411 Injection, thiamine hcl, 100 mg <1% 108 $4.53
J2004 Injection, lidocaine hcl with epinephrine, 1 mg <1% 113 $2.89
J0692 Injection, cefepime hydrochloride, 500 mg <1% 306 $2.69
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 690 $2.50
91308 <1% 275 $2.28
J1790 Injection, droperidol, up to 5 mg <1% 59 $2.20
J1626 Injection, granisetron hydrochloride, 100 mcg <1% 170 $1.96
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 298 $1.26
91312 <1% 83 $0.77
Q0245 Injection, bamlanivimab and etesevimab, 2100 mg <1% 19 $0.67
J2372 Injection, phenylephrine hydrochloride (biorphen), 20 micrograms <1% 131 $0.56
91315 <1% 52 $0.50
91317 <1% 54 $0.46
91303 <1% 39 $0.35
91306 <1% 31 $0.30
91305 <1% 60 $0.19
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 788 $0.00
C1776 Joint device (implantable) 0% 141 $0.00
76376 0% 163 $0.00
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 0% 32 $0.00
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries 0% 102 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 0% 433 $0.00
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) 0% 311 $0.00
C1760 Closure device, vascular (implantable/insertable) 0% 233 $0.00
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm 0% 118 $0.00
C1758 Catheter, ureteral 0% 320 $0.00
J7070 Infusion, d5w, 1000 cc 0% 625 $0.00
90380 0% 20 $0.00
J0640 Injection, leucovorin calcium, per 50 mg 0% 30 $0.00
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries 0% 17 $0.00
C1874 Stent, coated/covered, with delivery system 0% 14 $0.00
J9263 Injection, oxaliplatin, 0.5 mg 0% 66 $0.00
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) 0% 31 $0.00
A9577 Injection, gadobenate dimeglumine (multihance), per ml 0% 56 $0.00
96402 0% 18 $0.00
95874 0% 63 $0.00
J9190 Injection, fluorouracil, 500 mg 0% 69 $0.00
00170 Anesthesia for intraoral procedures, including biopsy 0% 13 $0.00
88313 0% 13 $0.00
C1726 Catheter, balloon dilatation, non-vascular 0% 328 $0.00
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 0% 382 $0.00
C2617 Stent, non-coronary, temporary, without delivery system 0% 191 $0.00
A9585 Injection, gadobutrol, 0.1 ml 0% 131 $0.00
84436 0% 15 $0.00
C1889 Implantable/insertable device, not otherwise classified 0% 116 $0.00
00126 0% 303 $0.00
80050 General health panel 0% 136 $0.00
94761 0% 1,021 $0.00
88311 0% 14 $0.00
C1781 Mesh (implantable) 0% 141 $0.00
86141 0% 15 $0.00
76377 0% 191 $0.00
77001 0% 138 $0.00
84479 0% 15 $0.00
J3360 Injection, diazepam, up to 5 mg 0% 16 $0.00
83090 0% 15 $0.00
90381 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSHARP, KEVIN (VICE PRESIDENT REVENUE CYCLE)
Same official

Other billing entities under SHARP, KEVIN

Full network →
ProviderLocationPaid
Emma L. Bixby Medical CenterAdrian, MI$18.35M
Bay Park Community HospitalOregon, OH$16.39M
Community Health Center of Branch CountyColdwater, MI$11.80M
Defiance Hospital INC.Defiance, OH$11.55M
Memorial HospitalFremont, OH$11.40M
Fostoria Hospital AssociationFostoria, OH$7.48M
Toledo HospitalToledo, OH$2.38M
Herrick Memorial Hospital, INC.Tecumseh, MI$1.82M
Flower HospitalSylvania, OH$368K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.